| Issue Date | Title | Author(s) |
| 2019-01-01 | Myopia: is the nature-nurture debate finally over? | Morgan, IG; Rose, KA |
| 2018-12-01 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants | Dadaev, T; Saunders, EJ; Newcombe, PJ; Anokian, E; Leongamornlert, DA; Brook, MN; Cieza-Borrella, C; Mijuskovic, M; Wakerell, S; Olama, AAA; Schumacher, FR; Berndt, SI; Benlloch, S; Ahmed, M; Goh, C; Sheng, X; Zhang, Z; Muir, K; Govindasami, K; Lophatananon, A; Stevens, VL; Gapstur, SM; Carter, BD; Tangen, CM; Goodman, P; Thompson, IM; Batra, J; Chambers, S; Moya, L; Clements, J; Horvath, L; Tilley, W; Risbridger, G; Gronberg, H; Aly, M; Nordström, T; Pharoah, P; Pashayan, N; Schleutker, J; Tammela, TLJ; Sipeky, C; Auvinen, A; Albanes, D; Weinstein, S; Wolk, A; Hakansson, N; West, C; Dunning, AM; Burnet, N; Mucci, L; Giovannucci, E; Andriole, G; Cussenot, O; Cancel-Tassin, G; Koutros, S; Freeman, LEB; Sorensen, KD; Orntoft, TF; Borre, M; Maehle, L; Grindedal, EM; Neal, DE; Donovan, JL; Hamdy, FC; Martin, RM; Travis, RC; Key, TJ; Hamilton, RJ; Fleshner, NE; Finelli, A; Ingles, SA; Stern, MC; Rosenstein, B; Kerns, S; Ostrer, H; Lu, YJ; Zhang, HW; Feng, N; Mao, X; Guo, X; Wang, G; Sun, Z; Giles, GG; Southey, MC; MacInnis, RJ; Fitzgerald, LM; Kibel, AS; Drake, BF; Vega, A; Gómez-Caamaño, A; Fachal, L; Szulkin, R; Eklund, M; Kogevinas, M; Llorca, J; Castaño-Vinyals, G; Penney, KL; Stampfer, M; Park, JY; Sellers, TA |
| 2018-07-01 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci | Schumacher, FR; Al Olama, AA; Berndt, SI; Benlloch, S; Ahmed, M; Saunders, EJ; Dadaev, T; Leongamornlert, D; Anokian, E; Cieza-Borrella, C; Goh, C; Brook, MN; Sheng, X; Fachal, L; Dennis, J; Tyrer, J; Muir, K; Lophatananon, A; Stevens, VL; Gapstur, SM; Carter, BD; Tangen, CM; Goodman, PJ; Thompson, IM; Batra, J; Chambers, S; Moya, L; Clements, J; Horvath, L; Tilley, W; Risbridger, GP; Gronberg, H; Aly, M; Nordström, T; Pharoah, P; Pashayan, N; Schleutker, J; Tammela, TLJ; Sipeky, C; Auvinen, A; Albanes, D; Weinstein, S; Wolk, A; Håkansson, N; West, CML; Dunning, AM; Burnet, N; Mucci, LA; Giovannucci, E; Andriole, GL; Cussenot, O; Cancel-Tassin, G; Koutros, S; Beane Freeman, LE; Sorensen, KD; Orntoft, TF; Borre, M; Maehle, L; Grindedal, EM; Neal, DE; Donovan, JL; Hamdy, FC; Martin, RM; Travis, RC; Key, TJ; Hamilton, RJ; Fleshner, NE; Finelli, A; Ingles, SA; Stern, MC; Rosenstein, BS; Kerns, SL; Ostrer, H; Lu, YJ; Zhang, HW; Feng, N; Mao, X; Guo, X; Wang, G; Sun, Z; Giles, GG; Southey, MC; MacInnis, RJ; Fitzgerald, LM; Kibel, AS; Drake, BF; Vega, A; Gómez-Caamaño, A; Szulkin, R; Eklund, M; Kogevinas, M; Llorca, J; Castaño-Vinyals, G; Penney, KL; Stampfer, M; Park, JY; Sellers, TA; Lin, HY; Stanford, JL; Cybulski, C |
| 2012-10-01 | Common variants at 6p21.1 are associated with large artery atherosclerotic stroke | Holliday, EG; Maguire, JM; Evans, TJ; Koblar, SA; Jannes, J; Sturm, JW; Hankey, GJ; Baker, R; Golledge, J; Parsons, MW; Malik, R; McEvoy, M; Biros, E; Lewis, MD; Lincz, LF; Peel, R; Oldmeadow, C; Smith, W; Moscato, P; Barlera, S; Bevan, S; Bis, JC; Boerwinkle, E; Boncoraglio, GB; Brott, TG; Brown, RD; Cheng, YC; Cole, JW; Cotlarciuc, I; Devan, WJ; Fornage, M; Furie, KL; Grétarsdóttir, S; Gschwendtner, A; Ikram, MA; Longstreth, WT; Meschia, JF; Mitchell, BD; Mosley, TH; Nalls, MA; Parati, EA; Psaty, BM; Sharma, P; Stefansson, K; Thorleifsson, G; Thorsteinsdottir, U; Traylor, M; Verhaaren, BFJ; Wiggins, KL; Worrall, BB; Sudlow, C; Rothwell, PM; Farrall, M; Dichgans, M; Rosand, J; Markus, HS; Scott, RJ; Levi, C; Attia, J |
| 2020-02-01 | Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes | Manchanda, R; Burnell, M; Gaba, F; Desai, R; Wardle, J; Gessler, S; Side, L; Sanderson, S; Loggenberg, K; Brady, AF; Dorkins, H; Wallis, Y; Chapman, C; Jacobs, C; Legood, R; Beller, U; Tomlinson, I; Menon, U; Jacobs, I |
| 2022-12 | Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. | Loveday, C; Garrett, A; Law, P; Hanks, S; Poyastro-Pearson, E; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Walker, L; Breast and Ovarian Cancer Susceptibility Collaboration,; Eccles, D; Evans, DG; Snape, K; Hanson, H; Houlston, RS; Turnbull, C |
